EUVIMEDOdkrijte EUVIMED
FallberichtOpen access

Topical Recombinant Collagen Following Fractional Radio Frequency Microneedling for Nonsurgical Facelift: Case Report

Thien-Chong Marcus Wong iD, Yizhi Ong iD

JMIR Dermatology · 2026-06-29 · 9 · e86892-e86892

DOI: 10.2196/86892 ↗

At a glance

Fallbericht in JMIR Dermatology, published online on 2026-06-29. Written by Thien-Chong Marcus Wong and 1 co-authors. Institution: Wong's Plastic Surgery Centre, Gleneagles Hospital, Singapore, Singapore. Major MEDLINE topics: Collagen, Rhytidoplasty. 9 references. The full text is freely available in PubMed Central.

PovzetekSubjectsBibliografski podatkiCiteRelated studies

Abstract (original language)

Background

Fractional radio frequency microneedling (FRM) is an effective nonsurgical facelift modality supported by growing clinical evidence. While generally well tolerated, postprocedural erythema, pain, swelling, and bruising typically last up to 7 days. Other serious complications include prolonged swelling, infection, persistent grid mark, burns, and hypo- or hyperpigmentation. Recombinant human collagen has demonstrated potent wound-healing and anti-inflammatory properties, which could be harnessed for post-FRM recovery.

Objective

To date, there is a lack of published studies evaluating the use of topical agents to improve postprocedural recovery following FRM. This case report describes the early experience of using topical recombinant collagen post FRM for nonsurgical facelift.

Methods

Two 40-year-old female patients with Fitzpatrick skin type IV underwent FRM for nonsurgical facelift. The procedure was performed with standard energy settings. Immediately post procedure, topical recombinant collagen was applied to the treated areas. Either clinical photography or cross-polarized imaging was used to objectively capture the changes in facial erythema and swelling.

Results

Both cases demonstrated a marked reduction of erythema and inflammation within 1 to 2 hours after application of topical recombinant collagen. These observations appeared earlier compared to the typical timeframe of 1 to 3 days. No adverse events were reported.

Conclusions

Topical recombinant collagen application post FRM was associated with an early reduction of skin erythema and inflammation.

Subjects

MeSH terms (MEDLINE)

CollagenRhytidoplastyHumansFemaleAdultPercutaneous Collagen InductionRecombinant ProteinsWound HealingSkin AgingNeedlesErythemaTreatment Outcome

Author keywords

fractional radio frequency microneedlingnonsurgical faceliftpostprocedure recoveryrecombinant human collagenwound healing

Substances

CollagenRecombinant Proteins

Authors and institutions

  • Wong's Plastic Surgery Centre, Gleneagles Hospital, Singapore, Singapore.
  • Department for Continuing Education, University of Oxford, Rewley House, 1 Wellington Square, Oxford, OX1 2IA, United Kingdom, +44 7428612914.

ORCID profiles: Thien-Chong Marcus Wong, Yizhi Ong

Cite

APA

Wong, T. M., & Ong, Y. (2026). Topical Recombinant Collagen Following Fractional Radio Frequency Microneedling for Nonsurgical Facelift: Case Report. JMIR Dermatology, 9, e86892-e86892. https://doi.org/10.2196/86892

Vancouver

Wong TM, Ong Y. Topical Recombinant Collagen Following Fractional Radio Frequency Microneedling for Nonsurgical Facelift: Case Report. JMIR Dermatology. 2026;9:e86892-e86892. doi:10.2196/86892

BibTeX
@article{Wong2026,
  author = {Wong, Thien-Chong Marcus and Ong, Yizhi},
  title = {Topical Recombinant Collagen Following Fractional Radio Frequency Microneedling for Nonsurgical Facelift: Case Report},
  journal = {JMIR Dermatology},
  year = {2026},
  volume = {9},
  pages = {e86892--e86892},
  doi = {10.2196/86892}
}
Start for free →